BioTuesdays

Category - Markets

Arcturus Logo
Markets

Ladenburg ups Arcturus Therapeutics to buy; PT $22

Ladenburg Thalmann upgraded Arcturus Therapeutics (NASDAQ:ARCT) to “buy” from “neutral” with a $22 price target after the company resolved a management dispute, “removing an organizational overhang since early February...

June 1, 2018
Exact Sciences Logo
Markets

BTIG ups Exact Sciences PT to $70 from $60

BTIG raised its price target for Exact Sciences (NASDAQ:EXAS) to $70 from $60 after the American Cancer Society expanded colorectal cancer screening guidelines. Shares of Exact were quoted at $57.99, up 10%, in...

May 30, 2018
ASLAN Pharmaceuticals
Markets

BTIG starts ASLAN Pharma at buy; PT $16

BTIG launched coverage of ASLAN Pharmaceuticals (NASDAQ:ASLN) with a “buy” rating and $16 price target. The stock closed at $6.85 on May 29. Singapore-based ASLAN is engaged in the development and commercialization of...

May 30, 2018
G1 Therapeutics Logo
Markets

HCW start G1 Therapeutics at buy; PT $61

H.C. Wainwright initiated coverage of G1 Therapeutics (NASDAQ:GTHX) with a “buy” rating and a $61 price target based on an outlook of the company’s pipeline. The stock closed at $49.20 on May 29. G1’s pipeline...

May 30, 2018
Savara Logo
Markets

HCW starts Savara at buy; PT $22

H.C. Wainwright initiated coverage of Savara (NASDAQ:SVRA) with a “buy” rating and $22 price target. The stock closed at $8.88 on May 25. Savara is developing two compounds, Molgradex, and AeroVanc that we believe, are...

May 28, 2018
Scynexis Logo
Markets

Ladenburg starts Scynexis at buy; PT $9

Ladenburg Thalmann launched coverage of Scynexis (NASDAQ:SCYX) with a “buy” rating and price target of $9. The stock finished at $1.59 on May 23. Scynexis is focused on developing a first-in-class antifungal, SCY-078...

May 24, 2018
Avid Bioservices
Markets

HCW starts Avid Bioservices at buy; PT $5

H.C. Wainwright launched coverage of Avid Bioservices (NASDAQ:CDMO) with a “buy” rating and $5 price target. The stock closed at $3.56 on May 23. Avid has accumulated 25 years of biologics cGMP experience, including...

May 24, 2018
Canaccord Logo
Markets

Canaccord cuts Vermillion to hold; PT to $1

Canaccord Genuity downgraded Vermillion (NASDAQ:VRML) to “hold” from “buy” and lowered its price target to $1 from $2.25 after the company’s first quarter results missed estimates across the board. The stock closed at...

May 24, 2018
Cesca Therapeutics Logo
Markets

HCW starts Cesca Therapeutics at buy; PT $1.50

H.C. Wainwright launched coverage of Cesca Therapeutics (NASDAQ:KOOL) with a “buy” rating and $1.50 price target. The stock closed at 53 cents on May 22. Cesca is focused on cell-based therapies and automated cell...

May 23, 2018
Citius Logo
Markets

HCW starts Citius Pharma at buy; PT $11

H.C. Wainwright initiated coverage of Citius Pharmaceuticals (NASDAQ:CTXR) with a “buy” rating and price target of $11. The stock finished at $2.40 on May 22. The company’s antibiotic lock therapy drug combination, Mino...

May 23, 2018